191 related articles for article (PubMed ID: 2361176)
1. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.
Marshall FH; Barnes S; Pinnock RD; Hughes J
Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms.
Marshall FH; Barnes S; Hughes J; Woodruff GN; Hunter JC
J Neurochem; 1991 Mar; 56(3):917-22. PubMed ID: 1993898
[TBL] [Abstract][Full Text] [Related]
3. In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin.
Voigt MM; Wang RY
Brain Res; 1984 Mar; 296(1):189-93. PubMed ID: 6324955
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
Pu SF; Zhuang HX; Han JS
Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain.
Boden PR; Woodruff GN; Pinnock RD
Br J Pharmacol; 1991 Mar; 102(3):635-8. PubMed ID: 1364831
[TBL] [Abstract][Full Text] [Related]
6. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
[TBL] [Abstract][Full Text] [Related]
7. A thyrotropin releasing hormone analog, DN-1417, increases endogenous dopamine release from slices of rat striatum and nucleus accumbens.
Yamada S; Kojima H; Tsutsumi T; Nakamura J; Anraku S; Nishi S; Inanaga K
Kurume Med J; 1983; 30 Suppl():S29-35. PubMed ID: 6434800
[No Abstract] [Full Text] [Related]
8. CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens.
Daugé V; Steimes P; Derrien M; Beau N; Roques BP; Féger J
Pharmacol Biochem Behav; 1989 Sep; 34(1):157-63. PubMed ID: 2626446
[TBL] [Abstract][Full Text] [Related]
9. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
Lane RF; Blaha CD; Phillips AG
Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin effects on evoked release of dopamine in slices from striatum, nucleus accumbens and prefrontal cortex in rat.
Hétier E; Boireau A; Dubédat P; Blanchard JC
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):13-7. PubMed ID: 3368012
[TBL] [Abstract][Full Text] [Related]
11. Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites.
Léna I; Roques BP; Durieux C
J Neurochem; 1997 Jan; 68(1):162-8. PubMed ID: 8978722
[TBL] [Abstract][Full Text] [Related]
12. The effects of cholecystokinin on the in vivo release of newly synthesized [3H]dopamine from the nucleus accumbens of the rat.
Voigt MM; Wang RY; Westfall TC
J Neurosci; 1985 Oct; 5(10):2744-9. PubMed ID: 4045551
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices.
Nurse B; Russell VA; Taljaard JJ
Neurochem Res; 1988 May; 13(5):403-7. PubMed ID: 3165497
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin-induced ventral root depolarization of neonate rat hemicord in vitro.
Long SK
Gen Pharmacol; 1993 Jan; 24(1):171-5. PubMed ID: 8097738
[TBL] [Abstract][Full Text] [Related]
15. Effects of systemic L-tyrosine on dopamine release from rat corpus striatum and nucleus accumbens.
During MJ; Acworth IN; Wurtman RJ
Brain Res; 1988 Jun; 452(1-2):378-80. PubMed ID: 3401745
[TBL] [Abstract][Full Text] [Related]
16. The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study.
Gerhardt GA; Friedemann M; Brodie MS; Vickroy TW; Gratton AP; Hoffer BJ; Rose GM
Brain Res; 1989 Oct; 499(1):157-63. PubMed ID: 2804664
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin-induced release of dopamine in the nucleus accumbens of the spontaneously hypertensive rat.
Kirouac GJ; Ganguly PK
Brain Res; 1995 Aug; 689(2):245-53. PubMed ID: 7583328
[TBL] [Abstract][Full Text] [Related]
18. Chronic lead exposure differentially affects dopamine transport in rat striatum and nucleus accumbens.
Missale C; Battaini F; Govoni S; Castelletti L; Spano PF; Trabucchi M
Toxicology; 1984 Oct; 33(1):81-90. PubMed ID: 6495347
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.
Reum T; Schäfer U; Marsden CA; Fink H; Morgenstern R
Neuropeptides; 1997 Feb; 31(1):82-8. PubMed ID: 9574843
[TBL] [Abstract][Full Text] [Related]
20. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.
Altar CA; Boyar WC
Brain Res; 1989 Apr; 483(2):321-6. PubMed ID: 2706523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
